###begin article-title 0
###xml 116 117 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Involvment of Cytosolic and Mitochondrial GSK-3beta in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons
###end article-title 0
###begin p 1
Conceived and designed the experiments: APP. Performed the experiments: APP FB JC. Analyzed the data: APP FB JC JC. Contributed reagents/materials/analysis tools: APP FB. Wrote the paper: APP JC.
###end p 1
###begin p 2
###xml 161 162 161 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 190 191 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 611 612 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 679 686 670 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 799 800 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1202 1203 1184 1185 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1417 1418 1396 1397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1629 1630 1605 1606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1819 1820 1792 1793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Aberrant mitochondrial function appears to play a central role in dopaminergic neuronal loss in Parkinson's disease (PD). 1-methyl-4-phenylpyridinium iodide (MPP+), the active metabolite of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), is a selective inhibitor of mitochondrial complex I and is widely used in rodent and cell models to elicit neurochemical alterations associated with PD. Recent findings suggest that Glycogen Synthase Kinase-3beta (GSK-3beta), a critical activator of neuronal apoptosis, is involved in the dopaminergic cell death. In this study, the role of GSK-3beta in modulating MPP+-induced mitochondrial dysfunction and neuronal death was examined in vivo, and in two neuronal cell models namely primary cultured and immortalized neurons. In both cell models, MPTP/MPP+ treatment caused cell death associated with time- and concentration-dependent activation of GSK-3beta, evidenced by the increased level of the active form of the kinase, i.e. GSK-3beta phosphorylated at tyrosine 216 residue. Using immunocytochemistry and subcellular fractionation techniques, we showed that GSK-3beta partially localized within mitochondria in both neuronal cell models. Moreover, MPP+ treatment induced a significant decrease of the specific phospho-Tyr216-GSK-3beta labeling in mitochondria concomitantly with an increase into the cytosol. Using two distinct fluorescent probes, we showed that MPP+ induced cell death through the depolarization of mitochondrial membrane potential. Inhibition of GSK-3beta activity using well-characterized inhibitors, LiCl and kenpaullone, and RNA interference, prevented MPP+-induced cell death by blocking mitochondrial membrane potential changes and subsequent caspase-9 and -3 activation. These results indicate that GSK-3beta is a critical mediator of MPTP/MPP+-induced neurotoxicity through its ability to regulate mitochondrial functions. Inhibition of GSK-3beta activity might provide protection against mitochondrial stress-induced cell death.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 182 212 182 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">substantia nigra pars compacta</italic>
###xml 219 222 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-deLau1">[1]</xref>
###xml 409 412 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Schapira1">[2]</xref>
###xml 414 417 414 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Mizuno1">[3]</xref>
Parkinson's disease (PD) is the second most common neurological disorder characterized by motor and behavioral disturbances caused by the degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) [1]. The molecular events underlying the loss of dopaminergic neurons in PD remain unclear, although substantial evidence suggest that mitochondrial dysfunction might be a major contributor [2], [3].
###end p 4
###begin p 5
###xml 316 319 316 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Schapira1">[2]</xref>
###xml 371 374 371 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Parker1">[4]</xref>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
Two of the most important functions of mitochondria relate to the production of ATP by oxidative phosphorylation and the mediation of signals for apoptotic cell death, the latter being particularly important in the context of PD. A defect in mitochondrial complex I activity in PD was identified in substantia nigra [2] as well as in platelet mitochondria of PD patients [4].
###end p 5
###begin p 6
###xml 372 375 372 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Dauer1">[5]</xref>
###xml 413 414 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 611 614 611 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Vila1">[6]</xref>
###xml 615 618 615 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Roucou1">[8]</xref>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 218 223 <span type="species:ncbi:9606">human</span>
Experimentally, inhibitors of complex I of the mitochondrial respiratory chain can produce the selective neuronal loss and consequent behavioral deficits mimicking PD hallmarks. For instance, in rodents, human and non-human primates, the neurotoxin 1-methyl-1,2,3,6-tetrahydropyridine (MPTP) mediates selective damage to dopaminergic neurons of the nigro-striatal pathway [5]. Neuronal cell death is caused by MPP+, the active metabolite of MPTP, which induces oxidative stress and the opening of the mitochondrial permeability transition pore (mPTP), the release of cytochrome c and the activation of caspases [6]-[8]. The mPTP results in increased permeability of the inner mitochondrial membrane to protons, ions and other solutes resulting in a decrease of the mitochondrial membrane potential (Deltapsim).
###end p 6
###begin p 7
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Embi1">[9]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Jope1">[10]</xref>
###xml 512 516 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Muyllaert1">[11]</xref>
###xml 517 521 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Lee1">[17]</xref>
###xml 712 716 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Grimes1">[18]</xref>
Glycogen Synthase Kinase (GSK)-3 is a proline-directed serine/threonine kinase originally identified as a regulator of glycogen synthase [9]. Gradually, GSK-3 appeared to be a multifaceted enzyme, affecting a wide range of biological functions including gene expression, cellular architecture and apoptosis [10]. Of the two closely related isoforms, GSK-3alpha and GSK-3beta, GSK-3beta is known to play critical roles in oxidative stress-induced neuronal apoptosis and pathogenesis of neurodegenerative diseases [11]-[17]. GSK-3beta is activated by phosphorylation of the tyrosine 216 residue (Tyr216) located in the kinase domain and inactivated by phosphorylation of the amino-terminal serine 9 residue (Ser9) [18].
###end p 7
###begin p 8
###xml 169 173 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Wang1">[19]</xref>
###xml 175 179 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-King1">[20]</xref>
###xml 383 387 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Youdim1">[21]</xref>
###xml 520 524 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Chen1">[22]</xref>
###xml 526 530 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-King2">[23]</xref>
###xml 532 536 520 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Lai1">[24]</xref>
###xml 292 297 <span type="species:ncbi:10090">mouse</span>
Recently, it has been shown that GSK-3beta inhibition protects dopaminergic neurons from MPTP toxicity, suggesting that GSK-3beta may play a key role in PD pathogenesis [19], [20]. Moreover, a chronic treatment with low lithium doses, a GSK-3beta inhibitor, could induce neuroprotection in a mouse model of MPTP-induced striatal dopaminergic neurodegeneration and dopamine depletion [21]. Finally, two other PD mimetics, 6-hydroxydopamine (6-OHDA) and rotenone, induce neuronal death through the activation of GSK-3beta [22], [23], [24].
###end p 8
###begin p 9
###xml 64 68 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Hoshi1">[25]</xref>
###xml 69 73 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Hetman1">[28]</xref>
###xml 300 304 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Feng1">[29]</xref>
###xml 305 309 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Zhou1">[32]</xref>
The presence of GSK-3beta within mitochondria has been reported [25]-[28]. Many reports indicate that the inhibition of GSK-3beta reduces ischemia/reperfusion cardiac injury through the regulation of the mPTP opening, indicating that it could exert its functions by modulating mitochondrial activity [29]-[32].
###end p 9
###begin p 10
###xml 88 89 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 157 164 154 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 258 259 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 448 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 999 1000 981 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
The present study was designed to investigate the putative role of GSK-3beta in MPTP/MPP+-induced mitochondrial dysfunction and dopaminergic neuronal death, in vivo, as well as in primary cultures of neuronal cells and immortalized neurons. Overall, MPTP/MPP+ induced the activation of GSK-3beta by the phosphorylation of Tyr216 in mouse brain and in both neuronal cell models. However, on subcellular fractions of neurons, we established that MPP+ treatment induced specific activation of the cytosolic pool whereas it decreased the mitochondrial pool of active GSK-3beta. This leads to the depolarization of the mitochondrial membrane, to the activation of caspase-9 and -3 and finally to neuronal cell death. Blockade of GSK-3beta activity by selective inhibitors i.e. lithium or kenpaullone or siRNA-mediated GSK-3beta knock-down efficiently abolished these effects. These findings suggest that GSK-3beta activity is critical for neuronal death in response to the mitochondrial stressor MPTP/MPP+.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Ethics statements
###end title 12
###begin p 13
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Experimental procedures on mice and the care given to animals have been approved by the French Regional Committee for Animal Use and Care # NCA/2004/06-02.
###end p 13
###begin title 14
Animals
###end title 14
###begin p 15
###xml 239 249 239 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Seven weeks-old male C57BL/6 mice were purchased from Charles River Laboratories (L'arbresle, France). All mice were held in a temperature-controlled room maintained under a 12-h light/dark cycle and had access to food and water available ad libitum.
###end p 15
###begin title 16
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo MPTP treatment
###end title 16
###begin p 17
###xml 585 589 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Przedborski1">[33]</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">Mice</span>
Adult mice (n = 5/group) received one intraperitoneal (i.p.) injection of MPTP per day (30 mg of free base/kg of body weight per injection; Sigma-Aldrich, St Quentin Fallavier, France) for five consecutive days whereas control mice (n = 5/group) were treated in the same conditions with vehicle only (0.9% NaCl). Mice were sacrificed 1, 3, 5, and 7 days after the last injection. After decapitation, collected brains were quickly frozen in 2-methyl butane at -30degreesC and kept at -20degreesC until use. MPTP handling and safety measures were in accordance with published guidelines [33].
###end p 17
###begin title 18
Immunohistochemistry
###end title 18
###begin p 19
###xml 135 141 <span type="species:ncbi:9986">rabbit</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
Brain coronal sections (12 microm thickness) were performed on a cryostat (Leica, Nussloch, Germany). For double-staining experiments, rabbit anti-TH (anti-Tyrosine Hydroxylase, Cell Signaling, St Quentin-en-Yvelines, France) was used together with mouse anti-phospho-Tyr216-GSK-3beta (BD Biosciences, Le Pont de Claix, France) as primary antibodies. Brain sections were permeabilized and blocked in PBS, pH 7.4, containing 0.2% CHAPS and 2% BSA (Sigma-Aldrich), then incubated with primary antibodies diluted in PBS, pH 7.4, containing 0.1% CHAPS and 2% BSA, for 3 h at room temperature. At the end of the incubation time, brain sections were washed three times with PBS and incubated with either Alexa488-conjugated or Texas-Red-conjugated secondary antibodies (Molecular Probes, Invitrogen, Cergy Pontoise, France) and diamidino-4',6-phenylindol-2 dichlorhydrate (DAPI) for 1 h at room temperature. Sections were then washed three times with PBS and prepared for microscopy observation.
###end p 19
###begin title 20
Cell cultures
###end title 20
###begin p 21
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 103 109 <span type="species:ncbi:9913">bovine</span>
Murine TSM1 neuronal cells were grown in Opti-MEM (Invitrogen) supplemented with 10% inactivated fetal bovine serum (FBSi, BioWest, Nuaille, France), 100 U/mL penicillin, 100 mg/mL streptomycin, and 0.1 g/L G418 (Invitrogen).
###end p 21
###begin p 22
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Dirikoc1">[34]</xref>
###xml 355 356 349 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Primary cultures of mouse neurons from embryonic day 13-14 C57BL/6 mice was carried out as described previously [34]. Briefly, neurons were cultured in Neurobasal medium containing B27 supplement (Invitrogen) and penicillin-streptomycin and used after 6-7 days of differentiation. Cell cultures were grown at 37degreesC in a humidified atmosphere of 5% C02 and 95% air.
###end p 22
###begin p 23
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 200 201 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 388 389 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
MPP+ (Sigma-Aldrich) was extemporaneously prepared by solubilization into appropriate cell culture medium. TSM1 and primary neuronal cell cultures were treated with the indicated concentrations of MPP+ for various times. Alternatively, neurons were pre-incubated for 15 min with indicated concentrations of LiCl or kenpaullone (kenp, Sigma-Aldrich) and then co-treated with 400 microM MPP+.
###end p 23
###begin title 24
siRNA cell transfection
###end title 24
###begin p 25
GSK-3beta-specific small interfering RNA (siRNA) or scrambled siRNA (Dharmacon, Perbio Science, Brebieres, France) were transfected into TSM1 cells using Oligofectamine (Invitrogen) according to the manufacturer's recommendations. Cells were used 48 h after transfection.
###end p 25
###begin title 26
Immunocytochemistry
###end title 26
###begin p 27
TSM1 and primary cultures of neurons were grown on polylysine-coated glass coverslips. After treatment, cells were fixed with 4% paraformaldehyde then permeabilized in PBS pH 7.4, containing 0.2% CHAPS and 2% BSA. Cells were then incubated for 3 h at room temperature with the appropriate primary antibody (dilution 1/200) in PBS, 0.1% CHAPS and 2% BSA. At the end of the incubation time, cells were washed three times with PBS and incubated with either Alexa488-conjugated or Texas-Red-conjugated secondary antibodies and DAPI for 1 h at room temperature. For mitochondria labeling, neurons were incubated with 100 nM MitoTracker Red CMXRostrade mark dye (Invitrogen) in the culture medium for 45 min at 37degreesC, then fixed, permeabilized and labeled for phospho-Tyr216-GSK-3beta as mentioned above. Finally, cells were washed three times with PBS and prepared for microscopy observation.
###end p 27
###begin title 28
Tetramethylrhodamine methyl ester (TMRM) labeling
###end title 28
###begin p 29
###xml 760 761 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 924 953 908 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</italic>
###xml 956 960 940 944 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mage</sc>
Coverslips with cells were mounted in a non perfusion holder (37degreesC) placed on the stage of a laser-scanning confocal microscope (TCS SP5, Leica Microsystems, Rueil-Malmaison, France) equipped with a 63x/1,4 oil immersion objective. One minute after the beginning of each experiment, cells were loaded with the potentiometric dye TMRM (Sigma-Aldrich) in Krebs-Ringer at a final concentration of 30 nM at 37degreesC. TMRM was excited at 561 nm and its fluorescence was detected through a 570-600 nm spectral window. In order to follow the dye equilibration between cytosolic and mitochondrial compartments, images were collected every 10 sec for 10 min. At the end of the equilibration period, neuronal cultures were treated with 5 microM carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP) (Sigma-Aldrich) as a control for mitochondrial membrane depolarization. The resulting image stacks were processed using "National Institutes of Health" Image softwaretrade mark. The fluorescence intensity kinetic plots were obtained by selecting 8 regions of interests (roi) and expressed as the mean+/-S.D. of the mean gray values derived from all the roi selected in each image.
###end p 29
###begin title 30
Western blotting
###end title 30
###begin p 31
###xml 1058 1087 1042 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</italic>
###xml 1090 1094 1074 1078 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mage</sc>
Cells were rinsed with PBS and homogenized in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA containing 0.5% Triton X-100 and 0.5% sodium deoxycholate). Equal amounts of total proteins (40 microg) determined by the Bradford method (BioRad, Marnes-La-Coquette, France) were separated onto 12% SDS-PAGE then transferred on nitrocellulose membrane (Schleicher & Schuell, Dassel, Germany). Blots were incubated in PBS 0.1% Tween, 1% milk with antibodies directed against GSK-3beta (Santa Cruz Biotechnologies, Tebu-Bio, Le Perray-en-Yvelines, France), phospho-Tyr216-GSK-3beta (BD Biosciences), phospho-Ser9-GSK-3beta (Cell Signaling), cytochrome c (BD Biosciences), and then with the appropriate HRP-secondary antibody. Blots were developed using an enhanced chemoluminescence system (ECL, Amersham, GE Healthcare, Orsay, France) with a LAS3000 detector (Fuji). To correct for any loading artifact, same blots were re-probed with either anti-beta-tubulin or anti-actin antibody (Abcam, Paris, France). Densitometry analyses were performed with a "National Institutes of Health" Image softwaretrade mark on the immuno-positive bands. Results were expressed as a percentage of control load.
###end p 31
###begin title 32
Cell fractionation
###end title 32
###begin p 33
Cells were lysed in buffer containing 20 mM Hepes, pH 7.5, 250 mM sucrose, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM dithiothreitol and a protease inhibitor mix (Roche, Basel, Switzerland). Homogenates were centrifuged at 750xg for 10 min at 4degreesC, then supernatants were collected and centrifuged at 10 000xg for 15 min at 4degreesC. Resulting pellets were mitochondrial-enriched fractions and were washed twice in order to minimize putative contamination with cytosolic proteins. Supernatants were further centrifuged at 100 000xg for 1 h at 4degreesC, the resulting pellets were microsomal-enriched fractions while supernatants contained cytosolic proteins.
###end p 33
###begin title 34
Cell survival measurement
###end title 34
###begin p 35
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS) assay (Promega, Charbonnieres-les-Bains, France), a marker of mitochondrial activity, was done according to the manufacturer's recommendations. The percentage of cell survival was calculated by dividing the absorbance value of the MPP+-treated samples by that of the untreated control within each group.
###end p 35
###begin title 36
Flow cytometry analyses
###end title 36
###begin p 37
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
MPP+- and untreated TSM1 neurons were pelleted and washed twice with PBS and the percentage of cells with active caspase-3 was assessed using PE-conjugated monoclonal active caspase-3 antibody kit (Pharmingen, BD Biosciences).
###end p 37
###begin p 38
To measure the mitochondrial membrane potential, TSM1 cells were stained with fluorescent probe JC-1 (5,5', 6, 6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazole carbocyanide iodide, BD Biosciences) at 1.0 microg/mL for 15 min at 37degreesC, washed and analyzed by flow cytometry. Photomultiplier settings were adjusted to detect green flurorescence of JC-1 monomers on FL-1 detector and the red fluorescence of JC-1 aggregates on the FL2 detector. Flow cytometry analysis was performed on a FACSCaliburtrade mark and the CELLQuesttrade mark software. Cells were gated according to size and scatter to eliminate dead cells and debris from analysis.
###end p 38
###begin title 39
Statistic analysis
###end title 39
###begin p 40
###xml 128 129 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 171 172 169 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Data were expressed as the mean+/-SD. Statistical analyses were performed using one-way analysis of variance (ANOVA) or Student t-test as indicated in the figure legends. p value<0.05 was considered as statistically significant.
###end p 40
###begin title 41
Results
###end title 41
###begin title 42
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
MPTP activated GSK-3beta in dopaminergic neurons of mouse brain and in two neuronal cell models
###end title 42
###begin p 43
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 214 244 214 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">substantia nigra pars compacta</italic>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Przedborski2">[35]</xref>
###xml 315 319 315 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-JacksonLewis1">[36]</xref>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
In vivo, MPTP treatment is a well characterized and suitable animal model of PD pathogenesis. MPTP is known to induce selective death of dopaminergic neurons (i.e. Tyrosine Hydroxylase, TH-positive neurons) in the substantia nigra pars compacta (SNc) and to reproduce neuropathological features of PD in mice [35], [36].
###end p 43
###begin p 44
###xml 56 63 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 500 509 491 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g001">Figure 1A</xref>
###xml 870 879 852 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g001">Figure 1B</xref>
###xml 974 981 956 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 684 689 <span type="species:ncbi:10090">mouse</span>
###xml 983 987 <span type="species:ncbi:10090">Mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
###xml 1387 1392 <span type="species:ncbi:10090">mouse</span>
In an attempt to study the role of endogenous GSK-3beta in vivo in MPTP-induced dopaminergic neuronal cell death, we first examined the activation of GSK-3beta (i.e phosphorylation at Tyr216 residue) in the SNc of MPTP-treated mice. Interestingly, immunohistochemistry analysis showed a selective activation of GSK-3beta in TH-positive neurons evidenced by enhanced phosphorylation at Tyr 216 in remaining TH-positive neurons 7 days post MPTP-treatment as compared to saline-injected control brains (Figure 1A). To further confirm that the MPTP treatment induced GSK-3beta activation, the phosphorylation state of Tyr216 residue of GSK-3beta was also evaluated by Western blotting in mouse brain homogenates. The level of phospho-Tyr216-GSK-3beta was significantly increased 7 days but not one day after the MPTP administration when compared to saline-treated controls (Figure 1B). In preliminary experiments, we established the kinetic of loss of TH-immunoreactive neurons in vivo. Mice were i.p. injected with 30 mg/kg every day for 5 consecutive days, then sacrificed 1, 3, 5 and 7 days after the last MPTP injection and brain sections were examined for TH immunoreactivity. Neuropathological examination of MPTP-treated mice revealed a progressive decrease in the number of TH-positive neurons in the SNc as early as 3 days after the MPTP treatment as compared to the saline-treated mouse brains. The maximal effect was observed 7 days after the last MPTP injection (data not shown).
###end p 44
###begin title 45
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 12 22 12 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in cellulo</italic>
###xml 55 56 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In vivo and in cellulo GSK-3beta activation by MPTP/MPP+.
###end title 45
###begin p 46
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 197 200 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 218 239 215 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 289 295 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">yellow</italic>
###xml 799 803 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 838 843 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 873 877 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctrl</italic>
###xml 885 886 867 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1177 1181 1139 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 1213 1218 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 1451 1452 1405 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1467 1473 1421 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
(A) Seven days after the last saline or MPTP administration, coronal midbrain slices from saline- or MPTP-treated mice were labeled with anti-TH antibody (green) and anti-phospho-Tyr216-GSK-3beta (red) as described in Materials and Methods. Merged micrographs illustrated the co-labeling (yellow) of anti-phospho-Tyr216-GSK-3beta and anti-TH antibodies. Images are representative of three independent experiments. (B) Saline and MPTP-treated mice were killed one or seven days after the end of the MPTP administration. The brains were homogenized and equal protein amounts were analyzed by Western blotting for phospho-Tyr216-GSK-3beta, total GSK-3beta and beta-tubulin contents. Arrowhead indicates the phospho-Tyr216-GSK-3beta, the upper immuno-positive band is a non specific labeling. (C) TSM1 (left) and primary cultures of neurons (right) were incubated with saline (ctrl) or MPP+ (400 microM) for the indicated times (0.5, 1, 2 and 4 h). Total proteins (40 microg) were analyzed for phospho-Tyr216-GSK-3beta, phospho-Ser9-GSK-3beta, total GSK-3beta and beta-tubulin by Western blotting. (D) Quantification of blots from three independents experiments performed on TSM1 (left) and primary cultured neurons (right). The phospho-Tyr216-GSK-3beta content in every condition was normalized to the total GSK-3beta content and expressed as percentage of the control condition. The results are mean+/-SD and statistical analysis was done using Student t-test. *p<0.01 versus untreated sample.
###end p 46
###begin p 47
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 58 62 58 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Orth1">[37]</xref>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 373 374 369 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 483 484 479 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 606 615 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g001">Figure 1C</xref>
###xml 621 622 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 873 889 857 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g001">Figure 1C and 1D</xref>
###xml 1060 1061 1038 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1213 1222 1187 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g001">Figure 1D</xref>
###xml 1246 1247 1220 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1457 1458 1425 1426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1570 1571 1538 1539 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1621 1630 1589 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g001">Figure 1C</xref>
###xml 267 273 <span type="species:ncbi:10090">murine</span>
MPP+ has been extensively used as an in vitro model of PD [37]. Based on preliminary results, we systematically used, in the following experiments with neuronal cells, a concentration of MPP+ leading to a significant cellular toxicity (i.e. 400 microM). Immortalized murine cortical neurons (TSM1) or primary cultures of neuronal cells were incubated in the presence of MPP+ iodide then Western blot analyses were performed on neuron homogenates in order to examine the effect of MPP+ on the phosphorylation of GSK-3beta at Tyr216 (i.e. activated GSK-3beta) and Ser9 residues (i.e. inactivated GSK-3beta) (Figure 1C). MPP+ rapidly increased the phosphorylation of GSK-3beta at residue Tyr216 in both neuronal cell types reaching a maximal effect after 1 and 2 h of incubation time for TSM1 and primary cultured neurons respectively as compared to the saline-treated cells (Figure 1C and 1D). Quantification after standardization of the same blots using the anti-beta-tubulin and anti-total GSK-3beta antibodies indicated a maximal effect after 1 and 2 h of MPP+ treatment in TSM1 cells and neurons in primary cultures respectively (126.5+/-2.3% and 180.1+/-4.5% compared to the control conditions taken as 100%) (Figure 1D). Surprisingly, the MPP+-induced GSK-3beta phosphorylation at Tyr216 was persistent over 4 h in primary cultured neurons whereas it was transient in TSM1. The level of GSK-3beta phosphorylation at residue Ser9 was less affected by MPP+ treatment than that of Tyr216. However, a slight increase of Ser9 phosphorylation was observed after 2 h of MPP+ treatment in primary cultures of neuronal cells (Figure 1C).
###end p 47
###begin title 48
###xml 84 85 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Pharmacological and siRNA-mediated down-regulation of GSK-3beta activity reduced MPP+-induced neuronal cell death
###end title 48
###begin p 49
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 218 227 218 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2A</xref>
###xml 267 268 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 410 419 394 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2A</xref>
TSM1 and primary cultures of neuronal cells were incubated in the presence of increasing concentrations of MPP+ iodide (from 0.1 to 2 mM) for 15 h and the cell viability was evaluated using the colorimetric MTS assay (Figure 2A). In both TSM1 and primary neurons, MPP+ induced neuronal cell death in a concentration dependent manner. In both cell types, 400 microM MPP+ induced approximately50% of cell death (Figure 2A).
###end p 49
###begin title 50
###xml 58 59 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Effect of the down-regulation of GSK-3beta activity on MPP+-induced neuronal cell death.
###end title 50
###begin p 51
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 393 397 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 429 434 427 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 536 537 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 611 615 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 644 649 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 753 754 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1034 1035 1006 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1041 1047 1013 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 1169 1170 1137 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1480 1501 1436 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 1597 1608 1550 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper panel</italic>
###xml 1736 1748 1686 1698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">middle panel</italic>
###xml 1842 1871 1789 1818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</italic>
###xml 1874 1878 1821 1825 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mage</sc>
###xml 2049 2050 1989 1990 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2436 2437 2363 2364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 2445 2446 2372 2373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 621 626 <span type="species:ncbi:10090">mouse</span>
(A) TSM1 and primary cultured neurons were treated with MPP+ (from 0.1 to 2 mM) for 15 h and cell viability was monitored by MTS assay. The data are expressed as the percentage of viable neurons when compared to untreated neurons and are the mean of three independent experiments with triplicate determinations +/-S.D. (B) Phase-contrast pictures of representative microscopic fields of TSM1 (left) and primary cultured neurons (right) pre-treated with 25 mM LiCl or 25 microM kenpaullone for 15 min, and then treated with saline or MPP+ for additional 15 h at 37degreesC. Magnification, x10. (C) TSM1 neurons (left) and mouse primary neurons (right) were pre-treated with LiCl or kenpaullone (25 mM and 25 microM, respectively), then incubated with MPP+ (400 microM) for 15 h at 37degreesC and cell viability was assessed using the MTS assay. The data are expressed as the percentage of viable neurons when compared to untreated neurons and are the mean of nine independent experiments with triplicate samples +/-S.D. One-way ANOVA *p<0.01 versus saline-treated cells. (D) TSM1 neurons were pre-treated with LiCl (25 mM) for 15 min and co-incubated with 400 microM MPP+ for the indicated times (0.5, 1, 2 and 4 h) and total proteins were extracted and anaylzed for phospho-Tyr216-GSK-3beta, total GSK-3beta and beta-tubulin contents by Western blotting. (E, F) TSM1 cells were transfected with scrambled siRNA (200 nM) or GSK-3beta specific siRNA (100 or 200 nM) as described in Materials and Methods. Two days post-transfection, cells lysates were analyzed for total GSK-3beta immunoreactivity (upper panel) by Western blotting (F). To determine the correction factor of load, blots were reprobed with the anti-beta-tubulin antibody (middle panel). The expression level of GSK-3beta was estimated by densitometry analyses performed with a "National Institutes of Health" Image software and expressed as the percent of control conditions. (E) Alternatively, scrambled- or GSK-3beta specific- siRNA-transfected cells were treated with 400 microM MPP+ for 15 h at 37degreesC and the cell viability was monitored using MTS assay. Survival rate in every group was normalized to the untreated control cells. Error bars represent the S.D. for three independent experiments. Statistically significant differences were obtained between siRNA specific GSK-3beta- and scrambled siRNA-transfected cells treated with 400 microM MPP+ using Student t-test (*p<0.05).
###end p 51
###begin p 52
###xml 60 64 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Stambolic1">[38]</xref>
###xml 123 124 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 231 232 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 290 294 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Kunick1">[39]</xref>
###xml 348 349 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 477 486 464 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2B</xref>
###xml 521 522 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 681 690 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2B</xref>
###xml 770 771 754 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 795 804 779 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2B</xref>
###xml 1022 1023 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1208 1209 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1228 1237 1208 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2C</xref>
###xml 1303 1304 1279 1280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1512 1513 1460 1461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1529 1538 1477 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2C</xref>
###xml 1651 1667 1595 1611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2B and 2C</xref>
Lithium chloride (LiCl), a selective inhibitor of GSK-3beta [38], was used to determine the implication of GSK-3beta in MPP+-induced neuronal cell death. TSM1 and primary cultured neurons were incubated for 15 h with 400 microM MPP+ in the presence of GSK-3beta inhibitors i.e. kenpaullone [39] and LiCl. Microscopy observations showed that the MPP+ treatment induced a significant decrease in the number of TSM1 cells and primary neurons as compared to the control condition (Figure 2B). Moreover, neurons exposed to MPP+ were dramatically damaged as reflected by the disappearance of normal cell bodies and the presence of shortened neuritis compared to untreated control cells (Figure 2B). The co-incubation with GSK-3beta inhibitors kenpaullone or LiCl prevented MPP+-induced neurotoxicity (Figure 2B). Neuronal viability was monitored by measuring the reduction of mitochondrial activity using the MTS assay. Preliminary experiments allowed us to show that the optimal protective effect of LiCl and kenpaullone on MPP+-induced cell death was obtained at 25 mM and 25 microM, respectively (data not shown). In TSM1 and primary cultures of neuronal cells, LiCl or kenpaullone significantly reduced the MPP+-induced toxicity (Figure 2C). Treatment of TSM1 cells and primary neurons with 400 microM MPP+ decreased by approximately60% and approximately80% the cell viability as compared to the control, respectively. Co-treatment with 25 mM LiCl or 25 microM kenpaullone significantly protected TSM1 from the MPP+-induced death (Figure 2C). No significant toxicity was found when neurons were incubated with 25 mM LiCl or 25 microM kenpaullone alone (Figure 2B and 2C).
###end p 52
###begin p 53
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 176 177 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 320 321 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 414 415 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 449 458 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2D</xref>
In an attempt to check the effect of LiCl on MPP+-induced GSK-3beta activation, TSM1 cells were pre-treated with 25 mM LiCl for 15 min and then co-incubated with 400 microM MPP+ for various incubation times. Western blot analyses using anti-phospho-Tyr216-GSK-3beta specific antibodies showed that LiCl prevented the MPP+-induced phosphorylation of GSK-3beta at Tyr216 residue suggesting that LiCl hampered the MPP+-induced activation of GSK-3beta (Figure 2D).
###end p 53
###begin p 54
###xml 96 97 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 374 383 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2E</xref>
###xml 436 437 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 634 635 604 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 665 666 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 754 763 721 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g002">Figure 2F</xref>
We used RNA interference, a gene silencing method, to further study the role of GSK-3beta in MPP+-induced neuronal cell death. GSK-3beta specific or control siRNA were transfected into TSM1 neurons and the level of GSK-3beta was estimated by Western blot analysis. 200 nM of specific GSK-3beta siRNA induced a approximately70% decrease of the expression level of GSK-3beta (Figure 2E). siRNA transfected cells were then treated with MPP+ for an additional 15 h and the cell viability was monitored. The survival of GSK-3beta siRNA-transfected cells was about 40% higher than that of the scrambled siRNA-transfected cells following MPP+ treatment indicating that MPP+-induced neurotoxicity was at least partially dependent on the expression of GSK-3beta (Figure 2F).
###end p 54
###begin title 55
###xml 34 35 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
GSK-3beta inhibitors prevented MPP+-induced caspase-9 and caspase-3 activation
###end title 55
###begin p 56
###xml 92 93 92 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 294 302 294 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g003">Figure 3</xref>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 642 658 638 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g003">Figure 3A and 3D</xref>
###xml 881 897 873 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g003">Figure 3B and 3E</xref>
###xml 1045 1054 1037 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g003">Figure 3C</xref>
###xml 1086 1102 1078 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g003">Figure 3D and 3E</xref>
###xml 1112 1113 1104 1105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1225 1226 1217 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1264 1276 1256 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g003">Figure 3A&#8211;3E</xref>
###xml 1381 1382 1373 1374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1485 1486 1477 1478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1699 1700 1691 1692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
To further characterize the intracellular pathways involved in the cell death induced by MPP+, we examined by fluorimetric assays and Western blot the activation of caspase-9 and caspase-3 after incubation with MPP+ in the presence or in the absence of pre-treatment with LiCl and kenpaullone (Figure 3). The MPP+ treatment induced a significant activation of caspase-9 in both neuronal models as compared to the untreated control, the maximal significant effect being observed after a 2 h-treatment for TSM1 cells and a 1 h-treatment for primary neurons (129.37+/-11.61% and 165.80+/-10.92% compared to the control conditions taken as 100%, Figure 3A and 3D). Significant caspase-3 activation was also observed in both cell types after as soon as 1 h after MPP+ treatment, reaching 138.84+/-5.44% of the control in TSM1 cells and 182.26+/-6.10% of the control in primary neurons (Figure 3B and 3E). Western blot analysis confirmed the increase of active caspase-3 immunoreactivity and the concomitant decrease of total caspase-9 level in TSM1 (Figure 3C) and primary cultured neurons (Figure 3D and 3E) upon MPP+ treatment. As shown by fluorimetric and Western blot analysis, pre-incubation with 25 mM LiCl prevented the MPP+-induced caspase-9 and -3 activation (Figure 3A-3E). Similar results were found by flow cytometry analysis of activated caspase-3 after incubation with MPP+ in the presence or in the absence of pre-treatment with LiCl and kenpaullone (data not shown). The MPP+ treatment induced the activation of caspase-3 in TSM1 neurons up to 233.9% as compared to the untreated control of active caspase-3 content of TSM1 cells. Pre-incubation with LiCl or kenpaullone minimized the MPP+-induced caspase-3 activation (194.9% and 198.3%, respectively).
###end p 56
###begin title 57
###xml 34 35 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
GSK-3beta inhibitors prevented MPP+-induced caspases-9 and -3 activation.
###end title 57
###begin p 58
###xml 104 105 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 482 483 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 493 494 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 501 507 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 609 613 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctrl</italic>
###xml 621 622 615 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 882 883 864 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1260 1261 1240 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1269 1270 1249 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1276 1282 1256 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 1471 1475 1451 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctrl</italic>
###xml 1483 1484 1463 1464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A, B, C) TSM1 neurons were pre-treated with saline or 25 mM LiCl and then incubated with 400 microM MPP+ for indicated times (1, 2, 4, or 6 h). Intracellular caspase-9 (A) and caspase-3 (B) activities were measured by fluorescence enzymatic assay in cell homogenates. The data are expressed as the percentage of control when compared to untreated neurons and are the mean of three independent experiments with triplicate samples +/-S.D. Statistical analysis was done using Student t-test (***p<0.005 versus untreated sample). (C) TSM1 cells were pre-treated or not with 25 mM LiCl and incubated with saline (ctrl) or MPP+ (400 microM) for 1 or 2 h. Total proteins (40 microg) were analyzed for active caspase-3, total caspase-9 and actin contents by Western blotting. (D, E) Primary cultured neurons were pre-treated with saline or 25 mM LiCl and then incubated with 400 microM MPP+ for indicated times (1, 2, 4, or 6 h). Intracellular caspase-9 (D) and caspase-3 (E) activities were measured by fluorescence enzymatic assay in cell homogenates. The data are expressed as the percentage of control when compared to untreated neurons and are the mean of three independent experiments with triplicate samples +/-S.D. Statistical analysis was done using Student t-test (*p<0.05 versus untreated sample). Total caspase-9 (D) and active caspase-3 (E) contents were analyzed by Western blotting of primary neurons pre-treated or not with 25 mM LiCl and incubated with saline (ctrl) or MPP+ (400 microM) for 1 or 2 h.
###end p 58
###begin title 59
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
MPP+ differentially affected GSK-3beta phosphorylation at residue Tyr216 in mitochondrial and cytosolic fractions
###end title 59
###begin p 60
###xml 64 67 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 254 258 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Ohori1">[27]</xref>
###xml 260 264 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Gomez1">[31]</xref>
###xml 266 270 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Das1">[40]</xref>
###xml 774 783 741 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4A</xref>
###xml 824 825 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 942 943 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1161 1162 1125 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1326 1327 1287 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1345 1361 1306 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4B and 4C</xref>
###xml 1473 1474 1431 1432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1486 1502 1444 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4B and 4C</xref>
###xml 1636 1637 1591 1592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1670 1679 1625 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4B</xref>
###xml 2128 2137 2077 2086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4B</xref>
###xml 2250 2251 2196 2197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2331 2340 2277 2286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4C</xref>
Previous studies have shown that GSK-3beta exerts its functions via the mitochondrial activity, by modulating transport through the outer membrane of the mitochondria, regulating the opening of the mPTP or mediating the access of Bax to the mitochondria [27], [31], [40]. Using immunocytochemistry we first checked that in our neuronal models GSK-3beta was indeed detectable within mitochondria. To do so, TSM1 and primary cultured neurons were loaded with the MitoTrackertrade mark dye, then stained with phospho-Tyr216-GSK-3beta specific antibody. Microscopy observation revealed that in both neuronal models, phospho-Tyr216-GSK-3beta partially localized within mitochondria as evidenced by the overlap between phospho-Tyr216-GSK-3beta and MitoTrackertrade mark labeling (Figure 4A). We then investigated the effect on MPP+ treatment on the subcellular distribution of active and inactive forms of GSK-3beta in TSM1 and primary neurons. MPP+-treated or untreated cells were submitted to differential subcellular fractionation and extracted proteins from the cytosolic and mitochondrial compartments were analyzed by Western blot. As early as 1 h after the MPP+ treatment, there was a marked decrease in phospho-Tyr216-GSK-3beta in the mitochondrial fractions of both cell types that was even more pronounced after 2 h of MPP+ incubation time (Figure 4B and 4C). On the opposite, the cytosolic fraction of phospho-Tyr216-GSK-3beta was significantly increased after the MPP+ treatment (Figure 4B and 4C). The mitochondrial and cytoplasmic fractions of the inactive form of the kinase i.e. phospho-Ser9-GSK-3beta were not affected by MPP+ treatment in both compartments (Figure 4B). No significant effect was shown on the subcellular distribution of total GSK-3beta, suggesting that modifications of the level of active form of GSK-3beta likely resulted from specific phosphorylation mechanisms and not from protein relocation or neosynthesize process. To monitor the purity of mitochondrial and cytosolic fractions, COXIV and GAPDH immunoreactivities were assessed as mitochondrial and cytosolic specific markers, respectively (Figure 4B). Interestingly, the modifications of phospho-Tyr216-GSK-3beta in cytosolic and mitochondrial fractions upon MPP+ treatment were significantly reduced by LiCl pre-treatment in both cell types (Figure 4C).
###end p 60
###begin title 61
###xml 57 58 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
GSK-3beta partially localized within mitochondria and MPP+ differentially affected phospho-Tyr216-GSK-3beta in mitochondrial and cytosolic fractions.
###end title 61
###begin p 62
###xml 119 122 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 193 198 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 218 222 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blue</italic>
###xml 265 269 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 301 306 289 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 340 341 324 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 476 497 460 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 870 874 842 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 906 911 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 1017 1018 989 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1027 1028 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1038 1039 1010 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1049 1050 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1057 1063 1029 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
(A) Fluorescence microscopy pictures of TSM1 and primary cultures of neurons loaded with 100 nM MitoTrackertrade mark (red), then fixed, permeabilized and stained for phospho-Tyr216-GSK-3beta (green) and nuclei (DAPI, blue). Magnification x25. (B, C) TSM1 neurons (left) and cultured primary neurons (right) were treated with 400 microM MPP+ for 1 and 2 h then submitted to subcellular fractionation in order to separate mitochondrial and cytosolic fractions, as described in Materials and Methods. Both fractions were analyzed for phospho-Tyr216-GSK-3beta, phospho-Ser9-GSK-3beta, total GSK-3beta, COXIV and GAPDH contents by Western blotting (B). (C) Densitometry analyses of four to eight independent experiments were carried out to quantify the phospho-Tyr216-GSK-3beta content in mitochondrial and cytosolic cellular fractions of vehicle- and LiCl-pretreated TSM1 (left) and primary cultured neurons (right). Data are expressed as percentage of the untreated samples. Statistical analysis was done using Student t-test (* p<0.05, ** p<0.01, ***p<0.005 versus untreated sample).
###end p 62
###begin title 63
###xml 87 88 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Pharmacological and siRNA-mediated down-regulation of GSK-3beta activity attenuated MPP+-induced decrease of mitochondrial membrane potential
###end title 63
###begin p 64
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Schapira2">[41]</xref>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 394 395 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 661 662 652 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 741 750 728 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5A</xref>
###xml 785 786 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 931 932 918 919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 989 998 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5A</xref>
###xml 1193 1194 1174 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1471 1472 1449 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1484 1493 1462 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5B</xref>
###xml 1583 1584 1561 1562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1741 1742 1716 1717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
One common feature of PD is the reduction of complex I activity in the SNc, supporting the hypothesis that nigral dopaminergic neurons are highly vulnerable to stress arising from mitochondrial dysfunction [41]. To investigate the involvement of mitochondria in MPP+-induced neuronal cell death through GSK-3beta activation, we analyzed the changes of mitochondrial membrane potential after MPP+ treatment by flow cytometry analysis using the fluorescent probe JC-1. JC-1 is selectively taken up by the mitochondria and is a reliable indicator of change of the mitochondrial membrane potential (DeltaPsim). We first studied the effects of a dose-response of MPP+ (from 100 to 600 microM) on mitochondrial membrane potential in TSM1 neurons (Figure 5A). Increasing concentrations of MPP+ induced a dose-dependent reduction of the fluorescence intensity as compared to that obtained with untreated cells, indicating a progressive MPP+-dependent depolarization of the mitochondrial membrane (Figure 5A). To investigate whether GSK-3beta exerts its neurotoxic role by modifying the mitochondria membrane potential, scrambled or GSK-3beta specific siRNA-transfected TSM1 cells were treated with MPP+ alone or in combination with LiCl or kenpaullone. The number of cells with depolarized mitochondrial membrane potential remained unchanged in GSK-3beta specific siRNA-transfected cells whereas it was increased by a two-fold factor in scrambled siRNA-transfected cells upon MPP+ treatment (Figure 5B). As expected, pre-treatment with LiCl or kenpaullone totally abolished the effect of MPP+ on the mitochondrial membrane potential in scrambled siRNA-transfected cells. These results indicate that the expression of GSK3beta is required for the MPP+-induced alterations of the mitochondrial membrane potential.
###end p 64
###begin title 65
###xml 28 29 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
GSK-3beta contributed to MPP+-induced TSM1 neuronal cell death through alterations of the mitochondrial membrane potential.
###end title 65
###begin p 66
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 368 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kenp</italic>
###xml 404 405 397 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 473 494 462 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Materials and Methods</xref>
###xml 1162 1167 1141 1146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 1186 1189 1165 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
(A) TSM1 neurons were treated with the indicated concentrations of MPP+ for 8 h then cells were stained with JC-1 and analyzed by flow cytometry. (B) TSM1 cells were cultured for 24 h then transfected with scrambled or GSK-3beta-specific siRNA (200 nM). Two days post-transfection, cells were pre-treated with saline buffer or 25 mM LiCl or 25 microM kenpaullone (kenp), then co-incubated or not with MPP+ (400 microM) for 8 h. Cells were stained with JC-1 as described in Materials and Methods and prepared for flow cytometry analysis. The results are expressed as the percent of cells with depolarized mitochondrial membrane potential (Psim). (C, D) intact primary neurons were pre-treated of not with 25 mM LiCl, then co-incubated or not with MPP+ (400 microM) for 4 h. Cells were placed on the stage on a laser-scanning confocal microscope and images were collected every 10 seconds for 10 minutes. One minute after the beginning of experiment, neurons were loaded with 30 nM TMRM (arrow) and one minute before the end of recording, 5 microM FCCP was added to the incubation medium (arrow). (C) Primary neurons pictures were collected 10 minutes after TMRM (green) and Hoechst dye (red) was added to the incubation medium. Magnification, x63. (D) The fluorescence intensity plots were obtained by selecting eight roi and expressed as the mean+/-S.D. of the mean gray values derived from all the selected roi in each image.
###end p 66
###begin p 67
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 517 518 517 518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 674 683 674 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5C</xref>
###xml 774 783 774 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5D</xref>
###xml 792 793 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 903 919 903 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5C and 5D</xref>
###xml 941 942 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1081 1082 1081 1082 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1151 1152 1151 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1200 1216 1200 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5C and 5D</xref>
###xml 1296 1305 1296 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5C</xref>
###xml 1463 1472 1463 1472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5D</xref>
###xml 1801 1810 1801 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g005">Figure 5D</xref>
###xml 1972 1973 1969 1970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
The fluorescent membrane-permeant cationic probe tetramethylrhodamine methyl ester (TMRM) has become one of the most frequently used probes in the analysis of variations of the mitochondrial membrane potential in intact cells because it exhibits very low toxicity and displays rapid and reversible membrane equilibration properties. We performed confocal microscopy analysis on intact primary cultured neurons in order to compare the kinetic and level of TMRM integration in mitochondria of control, MPP+ and LiCl/MPP+-treated neuronal cells. In control neurons, TMRM rapidly entered within mitochondria where it accumulated in an inner-membrane potential dependent manner (Figure 5C), as illustrated by the rapid increase of mean fluorescence intensity of untreated cells (Figure 5D). In MPP+-treated cells, TMRM only minimally entered within mitochondria and almost no TMRM fluorescence was detected (Figure 5C and 5D), indicating that MPP+ induced the depolarization of mitochondrial membrane potential. Interestingly, TMRM accumulated similarly in control cells and in LiCl/MPP+ co-treated neurons, suggesting that LiCl treatment prevented the MPP+-induced mitochondrial membrane depolarization (Figure 5C and 5D). LiCl treatment alone didn't affect mitochondria morphology and distribution (Figure 5C) and strongly increased TMRM mean fluorescence intensity during the course of the experiment, indicating that LiCl changed mitochondrial membrane potential (Figure 5D). FCCP, a mitochondrial uncoupler, was used as control because it induced a mitochondrial membrane potential collapse in intact cells. When FCCP was added to neurons, TMRM no longer accumulated inside mitochondria and became evenly distributed throughout the cytosol, as shown by the loss of TMRM fluorescence in control cells (Figure 5D).Taken together,these results indicated that GSK-3beta triggered a strong depolarization of the mitochondrial membrane potential in neuronal cells exposed to MPP+.
###end p 67
###begin title 68
Discussion
###end title 68
###begin p 69
###xml 69 70 66 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 169 170 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In the present study, we examined the implication of GSK-3beta in MPP+-induced mitochondrial dysfunction, and the putative protective role of GSK-3beta inhibition on MPP+-mediated neurotoxicity.
###end p 69
###begin p 70
###xml 256 272 256 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">substantia nigra</italic>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Keeney1">[42]</xref>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Beal1">[43]</xref>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Swerdlow1">[44]</xref>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
The role of mitochondria in the pathogenesis of several neurodegenerative disorders, including PD, has been well documented. Consistent deficits in the subunits and activity of mitochondrial complex I of the electron transport chain in blood platelets and substantia nigra of PD patients are prominent phenomena [42], [43]. Reduced complex I activity is also seen in cytoplasmic hybrid cell lines containing DNA from PD patients [44]. The role of mitochondrial dysfunction in PD also extends beyond that of a respiratory chain defect since mutations in three nuclear genes (PINK1, DJ1 and Omi) encoding mitochondrial proteins have been described in familial forms of PD. However, little is known regarding the molecular mechanisms leading to mitochondrial dysfunction but reduced mitochondrial membrane potential might be considered as an initial and irreversible step towards apoptosis.
###end p 70
###begin p 71
###xml 231 235 225 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Senatorov1">[45]</xref>
###xml 270 274 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Bijur2">[46]</xref>
###xml 309 313 300 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Alvarez1">[47]</xref>
###xml 315 319 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Wu1">[48]</xref>
###xml 629 633 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Bijur2">[46]</xref>
###xml 635 639 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Bijur3">[49]</xref>
###xml 641 645 629 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Watcharasit1">[50]</xref>
###xml 647 651 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Takadera1">[51]</xref>
###xml 825 829 810 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Bijur1">[26]</xref>
###xml 831 835 816 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Bijur4">[52]</xref>
###xml 837 841 822 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Ohori1">[27]</xref>
###xml 843 847 828 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Hetman1">[28]</xref>
###xml 976 980 958 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Doble1">[14]</xref>
###xml 982 986 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Beurel1">[53]</xref>
###xml 1229 1233 1205 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Linseman1">[54]</xref>
###xml 1235 1239 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Maurer1">[55]</xref>
###xml 1508 1512 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Park1">[30]</xref>
###xml 1514 1518 1487 1491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Obame1">[56]</xref>
###xml 1520 1524 1493 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Nishihara1">[57]</xref>
GSK-3beta is a well-known determinant in apoptotic process leading to neuronal cell death in several paradigms. For instance, the involvement of GSK-3beta in neuronal apoptosis has been demonstrated following excitotoxic treatment [45], staurosporine-induced cell death [46], beta-amyloid and MPTP treatments [47], [48]. Activated GSK-3beta, which inhibits heat shock transcription factor (HSTF)-1 and activates the mitochondrial death pathway, results in increased cytochrome c release from mitochondria. This, in turn, activates successively caspase-9 and caspase-3, accompanied by poly (ADP-ribose) polymerase (PARP) cleavage [46], [49], [50], [51]. Moreover, GSK-3beta has been shown to be located into several cell compartments such as cytosol, nucleus and mitochondria by both microscopy and immunoblotting experiments [26], [52], [27], [28]. The translocation of GSK-3beta from the cytosol to the nucleus is known to be one of the regulatory mechanisms of its function [14], [53]. However, the significance of the presence of GSK-3beta in mitochondria is still completely misunderstood. GSK-3beta may play crucial roles in the regulation of cell death and survival by modulating mitochondrial apoptotic cell death pathway [54], [55]. Interestingly, GSK-3beta has also been described to be involved in the regulation of opening of the mPTP, an event that can occur under conditions of oxidative stress or electron transport chain inhibition, leading to collapse of the mitochondrial membrane potential [30], [56], [57].
###end p 71
###begin p 72
###xml 86 87 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 297 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Lizcano1">[58]</xref>
###xml 336 343 330 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 610 611 598 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 657 664 645 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 828 829 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 992 993 974 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1149 1153 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Wang1">[19]</xref>
###xml 1155 1159 1134 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Chen1">[22]</xref>
The current study demonstrates several findings regarding the role of GSK-3beta in MPP+-induced mitochondrial dysfunction and neuronal cell death. The best-characterized mechanism for the inactivation of GSK-3beta occurs through the phosphorylation of its N-terminus at Ser9 by the kinase Akt [58]. However, in our study, we show that, in vivo, MPTP treatment induces a progressive loss of TH-positive neurons concomitant with an increase of phospho-Tyr216 GSK-3beta in remaining dopaminergic neurons, indicating that the activation of GSK-3beta by specific phosphorylation of Tyr216 may be involved in the MPP+-dependent neuronal cell death process. These in vivo results are in agreement with observations performed in immortalized TSM1 and primary cultured neurons. Indeed, in both neuronal cell types, the treatment with MPP+ induced an increase in the phosphorylation at Tyr216 of GSK-3beta whereas only negligible decrease in the amount of phospho-Ser9 GSK-3beta was observed. Thus, MPP+ does not appear to regulate the Akt-mediated phosphorylation of GSK-3beta on Ser9, a result that differs from previous studies using different cell models [19], [22].
###end p 72
###begin p 73
###xml 115 116 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 142 143 139 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 551 555 542 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Nishihara1">[57]</xref>
###xml 662 663 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1069 1078 1051 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005491-g004">Figure 4D</xref>
###xml 1155 1156 1134 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1389 1390 1365 1366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
We demonstrated for the first time a cellular compartment-specifc regulation process of GSK-3beta activity upon MPP+-treatment. Indeed, in MPP+-treated neurons, the active form of GSK-3beta increases in the cytosol and concomitantly decreases in the mitochondrial fraction leading to a collapse of the mitochondrial membrane potential. The translocation of GSK-3beta from the cytosol to mitochondria and its physical interaction with mitochondrial permeability transition pore complex has been previously suggested in an ischemia/reperfusion paradigm [57]. Despite the fact that the total GSK-3beta amount and its distribution do not appear to be affected by MPP+ treatment, we cannot rule out the possibility of a translocation of the active form of GSK-3beta from the mitochondria to the cytosol. Therefore, the active form of GSK-3beta present in mitochondria could be determinant for the maintenance of the mitochondrial membrane potential. Consistent with this hypothesis, LiCl-treated neurons present higher mitochondrial membrane potential than untreated cells (Figure 4D). Moreover, we showed that the regulation of GSK-3beta activity triggers MPP+-induced mitochondrial membrane depolarization, and subsequent mitochondrial-dependent activation of the caspase cascade. Taken together, our results suggest a dual role for active GSK-3beta according to its subcellular location. MPP+ induces neuronal cell death through the mitochondrial dysfunction closely related to the down-regulation of mitochondrial GSK-3beta activity and the up-regulation of active cytosolic form of the kinase.
###end p 73
###begin p 74
###xml 290 294 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Li1">[59]</xref>
###xml 357 361 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Nonaka1">[60]</xref>
###xml 363 367 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Nonaka2">[61]</xref>
###xml 453 460 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 491 494 479 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 607 611 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Youdim1">[21]</xref>
###xml 613 617 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Chen2">[62]</xref>
###xml 618 622 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Manji2">[65]</xref>
###xml 780 784 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Chen1">[22]</xref>
###xml 786 790 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Lai1">[24]</xref>
###xml 792 796 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Wu1">[48]</xref>
###xml 798 802 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Leng1">[66]</xref>
###xml 803 807 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Takadera2">[68]</xref>
###xml 884 888 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-King1">[20]</xref>
###xml 936 940 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Wang1">[19]</xref>
###xml 986 987 968 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1119 1120 1098 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Finally, to precisely evaluate the role of GSK-3beta in PD-related cell death, we inhibited GSK-3beta activity using two selective GSK-3beta inhibitors, LiCl and kenpaullone, and gene silencing with a siRNA targeting GSK-3beta. Lithium is widely used for the treatment of maniac depression [59], but it is also well known for its neuroprotective properties [60], [61]. Indeed, several reports have demonstrated that lithium, in neuronal cell models and in vivo, has neuroprotective activity via the up regulation of antiapoptotic and reduction of proapoptotic Bcl-2 family proteins, including Bcl-2 and Bax [21], [62]-[65]. Previous studies have demonstrated that GSK-3beta contributes to the death of a wide variety of cells including SH-SY5Y, PC12 or cerebellar granule neurons [22], [24], [48], [66]-[68]. Moreover, the specific inhibition of GSK-3beta could protect SH-SY5Y cells [20] and dopaminergic neurons against MPTP toxicity [19]. In this study, we show that LiCl blocked MPP+-induced phospho-Tyr216-GSK-3beta in both TSM1 and primary cultured neurons and that LiCl and kenpaullone protected neurons from MPP+-induced neuronal phenotypic damages, neurotoxicity and apoptotic cell death.
###end p 74
###begin p 75
###xml 123 127 120 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Gould1">[69]</xref>
###xml 129 133 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005491-Rowe1">[70]</xref>
###xml 242 243 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
GSK-3beta is likely the major target of lithium to elicit neuroprotection, although other targets have also been described [69], [70]. However, we show that silencing the expression of GSK-3beta by specific siRNA protected neurons against MPP+ toxicity and no synergistic neuroprotective effect of lithium can be observed, demonstrating that the neuroprotective effect of lithium actually involved GSK-3beta inhibition.
###end p 75
###begin p 76
###xml 77 78 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 660 661 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In summary, we clearly demonstrated the central role of GSK-3beta in MPTP/MPP+-mediated neuronal cell death and we showed that differential GSK-3beta regulations take place within mitochondria and cytosol. Further investigations will be required to precisely determine the role of mitochondrial GSK-3beta in physiological conditions. However, its activity may contribute to variation of the mitochondrial membrane potential. Our results highlight differential regulation of GSK-3beta activity according to its subcellular compartimentalization. Indeed, inhibition of GSK-3beta activity with specific inhibitors or siRNA significantly protected neurons from MPP+-induced cell death. New therapeutic strategy for PD targeting GSK-3beta inhibition deserves to be evaluated keeping in mind the specific regulation of the different GSK-3beta subcellular pools.
###end p 76
###begin title 77
References
###end title 77
###begin article-title 78
Epidemiology of Parkinson's disease.
###end article-title 78
###begin article-title 79
Mitochondrial complex I deficiency in Parkinson's disease.
###end article-title 79
###begin article-title 80
Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.
###end article-title 80
###begin article-title 81
Abnormalities of the electron transport chain in idiopathic Parkinson's disease.
###end article-title 81
###begin article-title 82
Parkinson's disease: mechanisms and models.
###end article-title 82
###begin article-title 83
Targeting programmed cell death in neurodegenerative diseases.
###end article-title 83
###begin article-title 84
Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.
###end article-title 84
###begin article-title 85
Conformational change of Bax: a question of life or death.
###end article-title 85
###begin article-title 86
###xml 32 38 <span type="species:ncbi:9986">rabbit</span>
Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.
###end article-title 86
###begin article-title 87
The glamour and gloom of glycogen synthase kinase-3.
###end article-title 87
###begin article-title 88
Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
###end article-title 88
###begin article-title 89
GSK-3 inhibitors for Alzheimer's disease.
###end article-title 89
###begin article-title 90
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
###end article-title 90
###begin article-title 91
GSK-3: tricks of the trade for a multi-tasking kinase.
###end article-title 91
###begin article-title 92
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
###end article-title 92
###begin article-title 93
Mechanistic insights into diabetes mellitus and oxidative stress.
###end article-title 93
###begin article-title 94
Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
###end article-title 94
###begin article-title 95
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
###end article-title 95
###begin article-title 96
Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
###end article-title 96
###begin article-title 97
Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium.
###end article-title 97
###begin article-title 98
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax.
###end article-title 98
###begin article-title 99
Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death.
###end article-title 99
###begin article-title 100
Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress.
###end article-title 100
###begin article-title 101
Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
###end article-title 101
###begin article-title 102
Different localization of tau protein kinase I/glycogen synthase kinase-3 beta from glycogen synthase kinase-3 alpha in cerebellum mitochondria.
###end article-title 102
###begin article-title 103
Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria.
###end article-title 103
###begin article-title 104
Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis.
###end article-title 104
###begin article-title 105
Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal.
###end article-title 105
###begin article-title 106
Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
###end article-title 106
###begin article-title 107
Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
###end article-title 107
###begin article-title 108
Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
###end article-title 108
###begin article-title 109
Ethanol prevents oxidant-induced mitochondrial permeability transition pore opening in cardiac cells.
###end article-title 109
###begin article-title 110
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.
###end article-title 110
###begin article-title 111
Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
###end article-title 111
###begin article-title 112
MPTP as a mitochondrial neurotoxic model of Parkinson's disease.
###end article-title 112
###begin article-title 113
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Protocol for the MPTP mouse model of Parkinson's disease.
###end article-title 113
###begin article-title 114
Models of Parkinson's disease.
###end article-title 114
###begin article-title 115
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.
###end article-title 115
###begin article-title 116
1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta.
###end article-title 116
###begin article-title 117
Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
###end article-title 117
###begin article-title 118
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
###end article-title 118
###begin article-title 119
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled.
###end article-title 119
###begin article-title 120
Mitochondria take center stage in aging and neurodegeneration.
###end article-title 120
###begin article-title 121
Origin and functional consequences of the complex I defect in Parkinson's disease.
###end article-title 121
###begin article-title 122
###xml 77 80 <span type="species:ncbi:10116">rat</span>
Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
###end article-title 122
###begin article-title 123
Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium.
###end article-title 123
###begin article-title 124
###xml 42 45 <span type="species:ncbi:10116">rat</span>
Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.
###end article-title 124
###begin article-title 125
Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway.
###end article-title 125
###begin article-title 126
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta.
###end article-title 126
###begin article-title 127
Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53.
###end article-title 127
###begin article-title 128
###xml 105 108 <span type="species:ncbi:10116">rat</span>
Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons.
###end article-title 128
###begin article-title 129
Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation.
###end article-title 129
###begin article-title 130
The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.
###end article-title 130
###begin article-title 131
Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis.
###end article-title 131
###begin article-title 132
Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1.
###end article-title 132
###begin article-title 133
Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
###end article-title 133
###begin article-title 134
Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection.
###end article-title 134
###begin article-title 135
The insulin signalling pathway.
###end article-title 135
###begin article-title 136
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain.
###end article-title 136
###begin article-title 137
Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx.
###end article-title 137
###begin article-title 138
###xml 17 20 <span type="species:ncbi:10116">rat</span>
Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine.
###end article-title 138
###begin article-title 139
Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity.
###end article-title 139
###begin article-title 140
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
###end article-title 140
###begin article-title 141
Neuroprotective effects of lithium in cultured cells and animal models of diseases.
###end article-title 141
###begin article-title 142
PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.
###end article-title 142
###begin article-title 143
Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition.
###end article-title 143
###begin article-title 144
Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3.
###end article-title 144
###begin article-title 145
###xml 119 122 <span type="species:ncbi:10116">rat</span>
Caspase-dependent apoptosis induced by thapsigargin was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical neurons.
###end article-title 145
###begin article-title 146
Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.
###end article-title 146
###begin article-title 147
Lithium neuroprotection: molecular mechanisms and clinical implications.
###end article-title 147
###begin p 148
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 148
###begin p 149
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by grants from "Fondation Pour La Recherche Medicale" () and "La Fondation de l'Avenir" (). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 149

